These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reactions of electrophiles with nucleophilic thiolate sites: relevance to pathophysiological mechanisms and remediation. LoPachin RM; Gavin T Free Radic Res; 2016; 50(2):195-205. PubMed ID: 26559119 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous Covalent Modification of K-Ras(G12D) and K-Ras(G12C) with Tunable Oxirane Electrophiles. Yu Z; He X; Wang R; Xu X; Zhang Z; Ding K; Zhang ZM; Tan Y; Li Z J Am Chem Soc; 2023 Sep; 145(37):20403-20411. PubMed ID: 37534597 [TBL] [Abstract][Full Text] [Related]
6. Optical Control of the GTP Affinity of K-Ras(G12C) by a Photoswitchable Inhibitor. Ge Z; Yang Z; Liang J; Dong D; Zhu M Chembiochem; 2019 Dec; 20(23):2916-2920. PubMed ID: 31219673 [TBL] [Abstract][Full Text] [Related]
8. K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology. Sakamoto K; Kamada Y; Sameshima T; Yaguchi M; Niida A; Sasaki S; Miwa M; Ohkubo S; Sakamoto JI; Kamaura M; Cho N; Tani A Biochem Biophys Res Commun; 2017 Mar; 484(3):605-611. PubMed ID: 28153726 [TBL] [Abstract][Full Text] [Related]
9. Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S). Zhang Z; Guiley KZ; Shokat KM Nat Chem Biol; 2022 Nov; 18(11):1177-1183. PubMed ID: 35864332 [TBL] [Abstract][Full Text] [Related]
10. Chemoselective Covalent Modification of K-Ras(G12R) with a Small Molecule Electrophile. Zhang Z; Morstein J; Ecker AK; Guiley KZ; Shokat KM J Am Chem Soc; 2022 Sep; 144(35):15916-15921. PubMed ID: 36001446 [No Abstract] [Full Text] [Related]
11. KRAS G12C Drug Development: Discrimination between Switch II Pocket Configurations Using Hydrogen/Deuterium-Exchange Mass Spectrometry. Lu J; Harrison RA; Li L; Zeng M; Gondi S; Scott D; Gray NS; Engen JR; Westover KD Structure; 2017 Sep; 25(9):1442-1448.e3. PubMed ID: 28781083 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic G12D mutation alters local conformations and dynamics of K-Ras. Vatansever S; Erman B; Gümüş ZH Sci Rep; 2019 Aug; 9(1):11730. PubMed ID: 31409810 [TBL] [Abstract][Full Text] [Related]
13. Covalent targeting of acquired cysteines in cancer. Visscher M; Arkin MR; Dansen TB Curr Opin Chem Biol; 2016 Feb; 30():61-67. PubMed ID: 26629855 [TBL] [Abstract][Full Text] [Related]
14. Computational investigation to identify potent inhibitors of the GTPase-Kirsten RAt sarcoma virus (K-Ras) mutants G12C and G12D. Kumar SU; Priya Doss CG Comput Biol Med; 2021 Dec; 139():104946. PubMed ID: 34715554 [TBL] [Abstract][Full Text] [Related]
15. Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Kuster GM; Pimentel DR; Adachi T; Ido Y; Brenner DA; Cohen RA; Liao R; Siwik DA; Colucci WS Circulation; 2005 Mar; 111(9):1192-8. PubMed ID: 15723974 [TBL] [Abstract][Full Text] [Related]
16. Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging. Niida A; Sasaki S; Yonemori K; Sameshima T; Yaguchi M; Asami T; Sakamoto K; Kamaura M Bioorg Med Chem Lett; 2017 Jun; 27(12):2757-2761. PubMed ID: 28457754 [TBL] [Abstract][Full Text] [Related]
17. WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors. Scarpino A; Petri L; Knez D; Imre T; Ábrányi-Balogh P; Ferenczy GG; Gobec S; Keserű GM J Comput Aided Mol Des; 2021 Feb; 35(2):223-244. PubMed ID: 33458809 [TBL] [Abstract][Full Text] [Related]
18. Drugging K-Ras Ni D; Li X; He X; Zhang H; Zhang J; Lu S Pharmacol Ther; 2019 Oct; 202():1-17. PubMed ID: 31233765 [TBL] [Abstract][Full Text] [Related]